Vanta Holdings talks up US peptide therapy plans after All-In Summit
The CSE-listed firm reported networking at the Los Angeles event but disclosed no agreements, partnerships, launch date or financial terms.
TR
By Tom Reyes · Markets Editor
Sep 18 13:16 ETSource: Kalkine Media
The wire
- 01Vanta Holdings said it attended the 2026 All-In Summit in Los Angeles on September 13 to 15 to advance a planned US peptide therapy platform.
- 02The company describes telehealth patient acquisition, physician consultation, FDA-registered compounding pharmacy fulfillment and subscription commercialization, a model operators in the compounded peptide space will recognize.
- 03No specific agreements, financial commitments or launch date were disclosed, and the immediate share price effect was not evident from public data.
From the source
Read at kalkinemedia.comVanta Holdings Advances U.S. Peptide Therapy Strategy at 2026 All-In Summit in Los Angeles
Why Does Barrick Mining (TSX:ABX) Matter in This TSX Session?